
University of Southampton, UK
Coordinator: Prof Eugen Stulz, School of Chemistry.
OLIGOMED comprises 12 beneficiaries: 8 world-class academic units, 1 leading hospital unit, 2 high-quality SMEs, and 1 world-leading pharmaceutical company.
Find below the links to the individual beneficiaries; contact details can be found in the Contact Us page.
Coordinator: Prof Eugen Stulz, School of Chemistry.
Dr Ling Peng, CINAM (UMR 7325)
Prof Roger Strömberg, Department of Biosciences and Nutrition.
Dr Krzysztof Kucharczyk, CEO, R&D
Prof Edvard Smith, Clinical Research Center at Karolinska University Hospital
Prof Philippe Barthélémy, INSERM U1212 / UMR CNRS 5320
Prof Annemieke Madder, Organic and Biomimetic Chemistry Research Group
Dr Shalini Andersson, Cardiovascular, Renal and Metabolic Diseases (CVRM)
Dr Carlo Vascotto, School of Medicine
Prof Florian Hollfelder, School of Biology
Dr Ulf Tedebark, Surface, Process and Formulation
Dr Anna Perdrix Rosell, Managing Director, R&D